These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23800501)

  • 1. The iScore predicts clinical response to tissue plasminogen activator in Korean stroke patients.
    Park TH; Park SS; Ko Y; Lee SJ; Lee KB; Lee J; Kang K; Park JM; Choi JC; Kim DE; Cho YJ; Hong KS; Kim JT; Kim DH; Cha JK; Han MK; Lee JS; Lee J; Yu KH; Lee BC; Yoon BW; Bae HJ; Saposnik G
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):367-73. PubMed ID: 23800501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
    Saposnik G; Demchuk A; Tu JV; Johnston SC;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Tissue Plasminogen Activator in Stroke Mimics.
    Ali-Ahmed F; Federspiel JJ; Liang L; Xu H; Sevilis T; Hernandez AF; Kosinski AS; Prvu Bettger J; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005609. PubMed ID: 31412730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
    Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
    Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
    Saposnik G; Reeves MJ; Johnston SC; Bath PM; Ovbiagele B;
    Stroke; 2013 Oct; 44(10):2755-9. PubMed ID: 23887844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clotting factors to treat thrombolysis-related symptomatic intracranial hemorrhage in acute ischemic stroke.
    Alderazi YJ; Barot NV; Peng H; Vahidy FS; Navalkele DD; Sangha N; Misra V; Savitz SI
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e207-14. PubMed ID: 24321775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.
    Xu X; Wang D; Wang F; Norton C; Liu X; Selim M
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2381-2387. PubMed ID: 29778315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S; Liang L; Kosinski A; Hernandez AF; Schwamm LH; Smith EE; Fonarow GC; Bhatt DL; Feng W; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e006031. PubMed ID: 31903770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The iScore predicts functional outcome in Korean patients with ischemic stroke.
    Park TH; Saposnik G; Bae HJ; Lee SJ; Lee KB; Lee J; Park JM; Choi JC; Kim DE; Cho YJ; Kim JT; Cha JK; Lee J; Yu KH; Lee BC; Yoon BW
    Stroke; 2013 May; 44(5):1440-2. PubMed ID: 23539526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.
    Liu H; Zheng H; Cao Y; Pan Y; Wang D; Zhang R; You S; Zhang X; Li S; Tong X; Liu CF; Wang Y
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):988-997. PubMed ID: 29224744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revised iScore to predict outcomes after acute ischemic stroke.
    Sung SF; Chen YW; Hung LC; Lin HJ
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1634-9. PubMed ID: 24709145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation and Validation of a Scoring System for Intravenous Tissue Plasminogen Activator Use in Asian Patients.
    Yeo LLL; Chien SC; Lin JR; Liow CW; Lee JD; Peng TI; Luen TH; Sharma V; Chan B; Lee TH;
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1695-1703. PubMed ID: 28408066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
    Minhas JS; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Donnan GA; Kim JS; Lavados PM; Lee TH; Martins SCO; Olavarría VV; Pandian JD; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Thang NH; Wang JG; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Cerebrovasc Dis; 2018; 45(5-6):213-220. PubMed ID: 29705803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.
    Whiteley WN; Thompson D; Murray G; Cohen G; Lindley RI; Wardlaw J; Sandercock P;
    Stroke; 2014 Apr; 45(4):1000-6. PubMed ID: 24603072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Wong LY; Ong BK; Chan BP; Teoh HL
    J Stroke Cerebrovasc Dis; 2010; 19(6):424-30. PubMed ID: 20554224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous tissue plasminogen activator for patients with minor ischemic stroke.
    Huisa BN; Raman R; Neil W; Ernstrom K; Hemmen TM
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):732-6. PubMed ID: 21531576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of the Turkish National Intravenous Thrombolysis Registry.
    Kutluk K; Kaya D; Afsar N; Arsava EM; Ozturk V; Uzuner N; Giray S; Topcuoglu MA; Gungor L; Sirin H; Yaka E; Ozdemir O; Dalkara T;
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1041-1047. PubMed ID: 26853139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of the THRIVE Score, the iScore Score and the ASTRAL Score in Chinese Patients With Acute Ischemic Stroke.
    Shen B; Yang X; Sui RB; Yang B
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2877-2886. PubMed ID: 30077603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.